100+ Free ABOG Complex Family Planning Practice Questions

Pass your ABOG Complex Family Planning Subspecialty Qualifying Examination exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

~85-90% Pass Rate

100+ Questions

100% Free

1 / 100

Question 1

Score: 0/0

A 28-year-old presents for first-trimester medication abortion at 7 weeks' gestation. Which is the current evidence-based regimen recommended by the WHO and ACOG?

Mifepristone 600 mg PO followed by misoprostol 400 µg vaginal 24-48 hours later

Mifepristone 200 mg PO followed by misoprostol 800 µg buccal 24-48 hours later

Methotrexate 50 mg/m² IM followed by misoprostol 800 µg vaginal 4-7 days later

Misoprostol 200 µg PO every 12 hours × 3 doses

to track

2026 Statistics

Key Facts: ABOG Complex Family Planning Exam

24 months

Fellowship Duration

ACGME-accredited Complex Family Planning

200 mg + 800 µg

Mifepristone + Misoprostol

First-trimester medication abortion

10 weeks

Medication Abortion Gestational Limit

Evidence-based upper bound

4 domains

CFP Blueprint Areas

Contraception / Abortion / EPL / Complications

~85-90%

First-Time Pass Rate

Subspecialty QE historical range

8 years

Certification Time Limit

From fellowship completion

The ABOG CFP Qualifying Exam is a computer-based single-best-answer MCQ examination administered annually at Pearson VUE testing centers. Content is organized by the ABOG CFP subspecialty blueprint, which emphasizes contraception (especially for medically complex patients), first- and second-trimester induced abortion (medication and procedural), early pregnancy loss, ectopic pregnancy, and complications management. Eligibility requires passing the ABOG Specialty QE, completion of a 24-month ACGME-accredited CFP fellowship, and a successfully defended thesis. Passing the QE is required to advance to the oral Certifying Exam.

Sample ABOG Complex Family Planning Practice Questions

Try these sample questions to test your ABOG Complex Family Planning exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 28-year-old presents for first-trimester medication abortion at 7 weeks' gestation. Which is the current evidence-based regimen recommended by the WHO and ACOG?

A.Mifepristone 600 mg PO followed by misoprostol 400 µg vaginal 24-48 hours later

B.Mifepristone 200 mg PO followed by misoprostol 800 µg buccal 24-48 hours later

C.Methotrexate 50 mg/m² IM followed by misoprostol 800 µg vaginal 4-7 days later

D.Misoprostol 200 µg PO every 12 hours × 3 doses

Explanation: The WHO/ACOG/SFP-recommended first-trimester medication abortion regimen is mifepristone 200 mg PO followed 24-48 hours later by misoprostol 800 µg buccal (or sublingual/vaginal). Efficacy is >95% through 10 weeks. The 600 mg mifepristone dose was historical and is not used. Methotrexate regimens are no longer standard for induced abortion. Misoprostol-only regimens (800 µg every 3 hours × up to 3 doses, ~85% efficacy) are used when mifepristone is unavailable.

2A 32-year-old with a history of estrogen-receptor-positive breast cancer 2 years ago (currently on tamoxifen) requests contraception. Per US MEC, which is Category 4 (unacceptable risk)?

A.Copper IUD

B.Combined oral contraceptives

C.Levonorgestrel IUD

D.Barrier methods

Explanation: Current breast cancer is US MEC Category 4 for all hormonal methods (COCs, POPs, DMPA, implant, LNG-IUD). Past breast cancer (>5 years cancer-free) may be Category 3 for hormonal methods. Copper IUD is Category 1-2 and provides highly effective non-hormonal contraception. Barrier methods and permanent sterilization are also acceptable. Patients on tamoxifen require non-hormonal contraception because tamoxifen is teratogenic.

3A patient at 18 weeks desires D&E for a fetal anomaly. What is the most appropriate cervical preparation regimen the day before the procedure?

A.Misoprostol 200 µg oral only

B.Osmotic dilators (Dilapan-S or laminaria) placed the day before, ± mifepristone 200 mg PO and/or misoprostol

C.Oxytocin infusion

D.Magnesium sulfate

Explanation: Second-trimester D&E cervical preparation options include osmotic dilators (Dilapan-S synthetic or laminaria seaweed-based) placed the day before. Adjuncts include mifepristone 200 mg PO (given the day before — approximately 24 hours prior) and/or misoprostol 400 µg buccal/vaginal 2-4 hours before procedure. The combination improves dilation and reduces procedure time. Single-agent misoprostol alone is less effective for second-trimester cervical preparation beyond 16 weeks.

4A 35-year-old with a prior severe DVT on lifelong anticoagulation desires a highly effective reversible contraceptive. Which option is US MEC Category 1?

A.Combined oral contraceptive

B.Estrogen patch

C.Levonorgestrel IUD

D.Combined vaginal ring

Explanation: Progestin-only methods (LNG-IUD, POP, DMPA, implant) and copper IUD are Category 1-2 in patients with current or prior DVT/PE on anticoagulation. Combined hormonal methods (pill, patch, ring) are Category 3-4 in these patients due to elevated VTE recurrence risk. LNG-IUD is an excellent choice — highly effective (Tier 1), minimal systemic absorption, and safe in thrombophilia. Copper IUD is non-hormonal and fully appropriate.

5At 19 weeks, a patient presents with intrauterine fetal demise. Which feticidal agent is typically used prior to D&E at 19-22 weeks in some practices?

A.Oxytocin

B.Digoxin 1-1.5 mg intrafetal or intra-amniotic, OR KCl 2 mEq intracardiac

C.Magnesium sulfate IV

D.No feticidal agent is needed

Explanation: For D&E at ≥18-20 weeks, some clinicians use feticidal agents to reduce the theoretical risk of transient fetal survival and to facilitate delivery. Digoxin 1-1.5 mg intrafetal or intra-amniotic is most common; KCl 2 mEq intracardiac is an alternative (more technically demanding; requires ultrasound guidance). Evidence does not show that feticidal agents improve procedure ease or safety. In IUFD at 19 weeks, feticidal agents are not needed.

6Which statement about misoprostol-only regimens for first-trimester medication abortion is MOST accurate?

A.Efficacy is ~85%, lower than mifepristone + misoprostol (~95%); misoprostol 800 µg vaginal/sublingual/buccal every 3 hours × up to 3 doses

B.Misoprostol-only is more effective than mifepristone + misoprostol

C.Misoprostol is contraindicated in abortion care

D.Misoprostol-only is only 50% effective in the first trimester

Explanation: Misoprostol-only regimens are used where mifepristone is unavailable. A typical regimen is 800 µg sublingual or vaginal every 3 hours × up to 3 doses, with efficacy ~85% for first-trimester abortion (lower than mifepristone + misoprostol at ~95-98%). Side effects (cramping, bleeding, diarrhea, chills) may be more prominent. Sublingual and vaginal routes are more effective than oral.

7A patient at 6 weeks with an incomplete miscarriage desires medication management. Which regimen has highest evidence-based efficacy?

A.Misoprostol 800 µg vaginal alone (71% by day 8)

B.Mifepristone 200 mg PO followed by misoprostol 800 µg vaginal 24 hours later (84-91%)

C.Oxytocin infusion

D.Methotrexate

Explanation: The PRAGMA trial (NEJM 2018) demonstrated that mifepristone 200 mg PO followed 24 hours later by misoprostol 800 µg vaginal had a significantly higher success rate (~84-91%) than misoprostol alone (~71%) for early pregnancy loss management. This combination regimen is now ACOG-recommended for medication management of EPL. If unsuccessful by day 8, suction aspiration or additional misoprostol is an option.

8Which Doubilet criterion definitively establishes early pregnancy failure on transvaginal ultrasound?

A.CRL 5 mm with no heartbeat

B.Mean gestational sac diameter ≥25 mm and no embryo

C.Empty gestational sac at any size

D.hCG of 1,500 with no IUP

Explanation: The 2013 Doubilet/SRU criteria for definitive pregnancy failure: (1) CRL ≥7 mm and no heartbeat; (2) Mean gestational sac diameter ≥25 mm and no embryo; (3) Absence of embryo with heartbeat ≥2 weeks after a scan showed a gestational sac without a yolk sac; (4) Absence of embryo with heartbeat ≥11 days after a scan showed a gestational sac with a yolk sac. CRL 5 mm is inconclusive; repeat imaging is required.

9A 26-year-old with an unruptured 2.5-cm tubal ectopic, hCG 3,200, no fetal cardiac activity, and no contraindications desires methotrexate. Which single-dose regimen is standard?

A.Methotrexate 50 mg/m² IM × 1 dose, with hCG levels on days 4 and 7; if decline <15% between days 4 and 7, repeat dose

B.Methotrexate 1 mg/kg IM × 4 doses on alternating days

C.Methotrexate 5 mg/m² IM daily × 5 days

D.Oral methotrexate 5 mg daily × 10 days

Explanation: Single-dose MTX protocol: 50 mg/m² IM × 1, with hCG drawn on days 1, 4, and 7. Success is defined as ≥15% decline between days 4 and 7; if <15%, repeat dose. Continue weekly hCG until undetectable. Two-dose regimen (50 mg/m² on days 0 and 4) has modestly higher success. Multi-dose MTX (1 mg/kg IM on days 1, 3, 5, 7 with leucovorin rescue) is reserved for larger ectopics or higher hCG.

10What is the most effective form of emergency contraception?

A.Levonorgestrel 1.5 mg PO

B.Ulipristal acetate 30 mg PO

C.Copper IUD (TCu-380A) inserted within 5 days of unprotected intercourse

D.Yuzpe method

Explanation: The copper IUD (TCu-380A) is the most effective emergency contraceptive (>99% effective, pregnancy rate <1 per 1,000) and provides ongoing contraception for up to 10-12 years. Ulipristal 30 mg PO is the most effective oral EC, effective up to 120 hours (5 days); preferred over LNG at 72-120 hours or BMI ≥30. LNG 1.5 mg PO is OTC, effective up to 72 hours (less effective after, in higher BMI). LNG 52 mg IUD also has 2023 FDA approval as EC.

About the ABOG Complex Family Planning Exam

The ABOG Complex Family Planning (CFP) Subspecialty Qualifying Examination is a written computer-based board examination for graduates of an ACGME-accredited Complex Family Planning fellowship. It is the first of the two-step ABOG subspecialty certification process and assesses knowledge and clinical judgment required for the independent practice of Complex Family Planning — contraception for patients with complex medical conditions, induced abortion care (first- and second-trimester medication and procedural abortion), early pregnancy loss management, ectopic pregnancy, and management of procedural complications. Passing the QE is prerequisite to sitting for the oral Certifying Examination (CE).

Questions

200 scored questions

Time Limit

Computer-based at Pearson VUE testing centers (exact duration set per cycle)

Passing Score

Scaled score with criterion-referenced cut-point set by ABOG

Exam Fee

Subspecialty QE fee per cycle (ABOG portal); $2,145 re-entry fee for 2026 (American Board of Obstetrics and Gynecology (ABOG))

ABOG Complex Family Planning Exam Content Outline

~40%

Contraception

US MEC for medically complex patients, LARC mechanisms and durations (copper TCu-380A up to 10-12 years, LNG 52 mg up to 8 years, LNG 19.5 mg 5 years, LNG 13.5 mg 3 years, etonogestrel implant 3 years with evidence up to 5), combined hormonal contraception (VTE risk, migraine with aura Category 4), DMPA, permanent sterilization (bilateral salpingectomy preferred over tubal ligation for ovarian cancer risk reduction). Difficult device placement, perforation, malposition, and expulsion management.

~30%

Induced Abortion

First-trimester medication abortion (mifepristone 200 mg PO + misoprostol 800 µg buccal) through 10 weeks; misoprostol-only regimens (800 µg every 3 hours × up to 3 doses, ~85% success). First-trimester aspiration abortion (manual or electric). Second-trimester D&E with cervical preparation (osmotic dilators, mifepristone 200 mg day before + misoprostol 400 µg buccal). Feticidal agents (digoxin 1-1.5 mg intrafetal/intra-amniotic, KCl intracardiac). Induction termination in second trimester.

~15%

Early Pregnancy Loss & Ectopic

Doubilet criteria for pregnancy failure (CRL ≥7 mm with no heartbeat; mean gestational sac diameter ≥25 mm with no embryo). EPL management: expectant (~80% success at 14+ days), medication (mifepristone 200 mg + misoprostol 800 µg vaginal 91% success vs misoprostol alone 71%), suction aspiration (99%). Ectopic pregnancy methotrexate (single-dose 50 mg/m², two-dose, multi-dose protocols). Molar pregnancy surveillance.

~15%

Complications & Systems-Based Practice

Postabortion hemorrhage (uterotonics: oxytocin, methylergonovine, carboprost, misoprostol; TXA 1 g IV; Bakri balloon or vacuum tamponade; UAE; hysterectomy as last resort). Uterine perforation, cervical laceration, retained POC. Anesthesia considerations. Ethics and professionalism, Dobbs decision and state-level regulatory landscape, mifepristone REMS, Society of Family Planning guidelines, research/QI methods.

How to Pass the ABOG Complex Family Planning Exam

What You Need to Know

Passing score: Scaled score with criterion-referenced cut-point set by ABOG
Exam length: 200 questions
Time limit: Computer-based at Pearson VUE testing centers (exact duration set per cycle)
Exam fee: Subspecialty QE fee per cycle (ABOG portal); $2,145 re-entry fee for 2026

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

ABOG Complex Family Planning Study Tips from Top Performers

1Memorize the first-trimester medication abortion regimen: mifepristone 200 mg PO Day 1, followed by misoprostol 800 µg buccal (or sublingual/vaginal) 24-48 hours later — effective through 10 weeks with >95% success; known contraindications include ectopic, IUD in place, chronic adrenal failure, long-term steroids, hemorrhagic disorder, and inherited porphyria

2Know the second-trimester D&E cervical preparation options: osmotic dilators (Dilapan-S or laminaria) placed the day before ± mifepristone 200 mg PO the day before ± misoprostol 400 µg buccal 2-4 hours before procedure — choose based on gestational age and patient factors

3Master US MEC Category 4 (unacceptable risk) for CHCs: current DVT/PE on non-anticoagulation, major surgery with immobilization, migraine with aura (any age), current breast cancer, hypertension ≥160/100, peripartum cardiomyopathy with severe impairment, complicated valvular heart disease, active viral hepatitis with cirrhosis, and current SLE with positive/unknown antiphospholipid antibodies

4Understand the Doubilet criteria definitive for pregnancy failure: (1) CRL ≥7 mm and no heartbeat on TVUS; (2) Mean gestational sac diameter ≥25 mm and no embryo; (3) Absence of embryo with heartbeat ≥2 weeks after scan showed gestational sac without yolk sac; (4) Absence of embryo with heartbeat ≥11 days after scan showed gestational sac with yolk sac

5For bilateral salpingectomy vs tubal ligation, counsel that salpingectomy is preferred permanent contraception (same efficacy) AND reduces high-grade serous ovarian cancer risk by ~50-80% (most HGSOC arises from the fimbrial tubal epithelium per OCP/distal fallopian tube theory); ACOG/SGO/AAGL consensus supports salpingectomy as the preferred approach

Frequently Asked Questions

What is the ABOG Complex Family Planning Subspecialty Qualifying Exam?

The ABOG CFP Qualifying Exam is a written computer-based multiple-choice board exam taken by graduates of an ACGME-accredited 24-month Complex Family Planning fellowship. It is the first of the two-step ABOG subspecialty certification process and assesses foundational knowledge in contraception (especially for medically complex patients), induced abortion care, early pregnancy loss, and management of complications. Candidates must pass the QE before sitting for the oral Certifying Examination (CE).

What topics are tested on the Complex Family Planning QE?

The ABOG CFP subspecialty blueprint emphasizes four domains: (1) Contraception — including US MEC for medically complex patients, LARC mechanisms, and permanent sterilization; (2) Induced abortion — first- and second-trimester medication and procedural abortion, cervical preparation, feticidal agents; (3) Early pregnancy loss and ectopic pregnancy management; and (4) Complications management and systems-based practice including ethics, research, and the regulatory landscape after Dobbs.

What are the eligibility requirements for the CFP QE?

Candidates must (1) hold current ABOG Specialty Active Candidate status by having passed the ABOG Specialty Qualifying Exam; (2) complete (or be within 4 months of completing) an ACGME-accredited 24-month Complex Family Planning fellowship — at least 20 of 24 months at application; (3) successfully defend a thesis before June 15 of the exam year; and (4) hold an unrestricted medical license if any license is held. Fellowship must be complete by September 30 of the exam year or results are voided.

What is the format and length of the CFP Qualifying Exam?

The CFP QE is a written computer-based examination delivered at Pearson VUE testing centers. It consists of single-best-answer multiple-choice questions, with many items constructed to be thought-provoking, problem-solving scenarios where all answer choices may be plausible but only one is most correct. Exact length is set per cycle by ABOG. The exam is delivered in English only.

What is the passing score and pass rate for the CFP QE?

ABOG reports a scaled score and pass/fail result. The cut-point is criterion-referenced and determined by standard-setting, not curved. Score reports include percent correct by major topic area. Subspecialty QE first-time pass rates are generally 85-90% depending on cycle and cohort. ABOG publishes historical pass rates annually and requires certification within 8 years of fellowship completion.

What is the highest-yield content for the CFP Qualifying Exam?

High-yield topics include: mifepristone 200 mg PO + misoprostol 800 µg buccal for first-trimester medication abortion (through 10 weeks); osmotic dilators + mifepristone + misoprostol for second-trimester D&E cervical preparation; US MEC Category 3/4 for medically complex patients (VTE, migraine with aura, cardiac disease, SLE with APLS, breast cancer); bilateral salpingectomy over tubal ligation (reduces ovarian cancer risk); Doubilet criteria for pregnancy failure (CRL ≥7 mm no heartbeat, MSD ≥25 mm no embryo); ectopic methotrexate criteria (hCG <5,000, size <3.5 cm, no cardiac activity); and postabortion hemorrhage management (uterotonic ladder, TXA, tamponade).

How is the CFP QE different from the ABOG Specialty QE?

The Specialty QE (general OB/GYN) is a broad exam with roughly 33% obstetrics, 33% gynecology, and 33% office practice, taken after residency. The CFP subspecialty QE is focused on contraception, induced abortion, early pregnancy loss, and procedural complications at a fellow level. Candidates must first pass the Specialty QE to become eligible for any subspecialty QE. The CFP QE includes content on complex contraceptive decisions for patients with significant medical comorbidities that general residents may not encounter.

How should I study for the ABOG CFP Qualifying Exam?

Use a structured 6-12 month study plan during fellowship. Review the Society of Family Planning Clinical Guidelines (contraceptive management, medication abortion, D&E, cervical preparation, management of complications), ACOG Practice Bulletins relevant to contraception and early pregnancy loss, US MEC for Contraceptive Use, and the WHO Medical Eligibility Criteria. Complete fellow-level Q-banks, review cases from your fellowship's case log, and take timed practice exams. Review research methodology and statistics (core component of the blueprint).